Skip to main content
OpenTrials
Completed

NCT Number: NCT06081413

Bariatric and Metabolic Surgery in Patients Over 65 Years of Age

A retrospective multicenter study that will analyze the results of surgical treatment of obesity in patients over 65 years of age.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 65 years of age and more
  • undergone bariatric surgery

Exclusion criteria

  • lost to follow up

Treatment and study plan

bariatric surgery

Procedure

bariatric surgeries - sleeve gastrectomy, roux-en-Y gastric bypass, one anastomosis gastric bypass, adjustable gastric band

Primary outcomes

  1. weight loss after bariatric surgery

    Time frame: until December 31, 2022

    how much weight patients lost, determined by BMI

  2. improvement in obesity-related diseases

    Time frame: until December 31, 2022

    changes in the treatment of hypertension and diabetes type 2 - whether the diseases resolved completely or whether there was a change in medications (in accordance with the guidelines of the American Society for Metabolic and Bariatric Surgery ASMBS)

Sponsors and collaborators

Lead sponsor

University of Warmia and Mazury in Olsztyn

Other

Registry information

Official study title

Bariatric and Metabolic Surgery in Patients Over 65 Years of Age - a Multicenter Study

Acronym: 65plus

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Oct 13, 2023
Registry last updated
Oct 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.